Topiramate titration and tolerability

Annals of Pharmacotherapy

Volumn 35, Issue 2, 2001, Pages 173-179

  Biton, V ^a   Edwards, K R ^a   Montouris, G D ^a   Sackellares, J C ^a   Harden, C L ^a   Kamin, M ^a  

^a Arkansas Epilepsy Program   (United States)

Author keywords

Antiepileptic; Epilepsy; Titration; Topiramate

Indexed keywords

TOPIRAMATE;

ADJUVANT THERAPY; ADULT; AMNESIA; ANOREXIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOCAL EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TITRIMETRY; TREATMENT OUTCOME; VERTIGO; VISUAL DISORDER;

EID: 0035142811     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.10093     Document Type: Article

References (23)

1. Topiramate: Preclinical evaluation of a structurally novel anticonvulsant
2. Clinical significance of animal seizure models and mechanisms of action studies of potential antiepileptic drugs
3. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages
4. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1000-mg daily dosages
5. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy
6. Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy
7. Double-blind, placebo-controlled trial of topiramate as addon therapy in patients with refractory partial seizures
8. Topiramate: Side effect profile in doubleblind studies
9. Safety of topiramate: Adverse events and relationships to dosing
10. Tolerability and safety of topiramate
11. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures
12. Efficacy and adverse effects of established and new antiepileptic drugs
13. Early tolerance to antiepileptic drug side effects: A controlled trial of 247 patients
14. Proposal for revised clinical and electroencephalographic classification of epileptic seizures
15. Serum anticonvulsant concentrations and the risk of drug-induced skin eruptions
16. Lamotrigine
17. Overview of lamotrigine and the new antiepileptic drugs: The challenge
18. Practical aspects of the use of topiramate in patients with epilepsy
19. Topiramate: Clinical profile in epilepsy
20. The office use of topiramate: A review of seizure control and side-effect profile
21. Role of topiramate (Topamax) in adults with intractable epilepsy, mental retardation, and developmental disabilities
22. Side effect profile of two different starting doses of topiramate